Owlet Inc. Secures Regulatory Approval for Launch of Medically-Certified Dream Sock™ in South Africa

Reuters
Sep 04
<a href="https://laohu8.com/S/OWLT">Owlet Inc.</a> Secures Regulatory Approval for Launch of Medically-Certified Dream Sock™ in South Africa

Owlet Inc., a leader in smart infant monitoring, has announced the launch of its medically-certified Dream Sock™ in South Africa, expanding the company's reach to a third continent. The Dream Sock is now distributed as a Class C Medical Device with CE Marking, allowing parents to monitor their baby's live vital signs and receive real-time health notifications. This product is NAPPI coded, enabling eligible consumers to claim reimbursement from their medical aid when purchased through authorized channels. This expansion marks a significant milestone for Owlet, as they continue to make hospital-grade monitoring technology accessible to more families worldwide.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Owlet Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250904415389) on September 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10